Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: iProceedings

Date Submitted: Jan 17, 2022
Open Peer Review Period: Jan 17, 2022 - Jan 28, 2022
Date Accepted: Jan 28, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of Routine Immunization Coverage in 12- to 23-Month Children in Sarepol Province, 2018: Descriptive Cross-sectional Study

Karimi AS Sr

Evaluation of Routine Immunization Coverage in 12- to 23-Month Children in Sarepol Province, 2018: Descriptive Cross-sectional Study

iProc 2022;8(1):e36536

DOI: 10.2196/36536

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Evaluation of routine immunization coverage in 12-23 months children in Sarepol province 2018: a descriptive cross-sectional study

  • Abdul Shakour Karimi Sr

ABSTRACT

Background:

Afghanistan has the lowest routine coverage, according to WHO-UNICEF reports. The coverage rate of Penta3 in Iran, India, Pakistan, and Afghanistan are estimated 99%, 89%, 75%, and 66% respectively. This study aims to find real coverage in urban area and related factors to vaccinated and un-vaccinated for 12-23 months children 2018 in Sarepol province.

Objective:

This study aims to find real coverage in urban area and related factors to vaccinated and un-vaccinated for 12-23 months children 2018 in Sarepol province.

Methods:

A descriptive cross-section study with probability-proportional-to-size (PPS) cluster sampling was conducted and modified for application to surveys of immunization coverage. We selected 30 clusters and randomly 7 households visited from each cluster in urban setting of Sarepol province. Children's ages were calculated, in months, with respect to the 1st day of the survey. We designed a comprehensive questionnaires of which 210 were filled. Data were managed and analyzed in Epi Info v.7.

Results:

This survey shows EPI routine coverage for 12-23 months children for BCG, Meales-1, Penta-1 and Penta3 were 97.14%, 77.14%, 93.81% and 83.81% respectively. Full immunized coverage by gender, 80.18% for girls and 71.15% for boys reported. Dropout rate of vaccine among penta-1, penta-3 and BCG, Measles-1 was 9.27% and 18.90% respectively. 2.86% of 12-23 months children still not received any vaccine in urban areas. The child being sick, immigration, health facilities was far and gaps between vaccine more reported by respondents as reasons for incomplete and no vaccination. Valid doses for BCG, Measles and Penat3 calculated 93.80%, 71.43% and 80% respectively

Conclusions:

It is observed that access and utilization of immunization services in urban areas have improved because full immunization was 75% versus AHS-2018 survey 61%. But, still there is a lot of children who did not receive any vaccine. High immunization drop-out rates could be overcome by creating awareness of the program and of the relevance of second and third doses of Penta, polio and measles vaccines. Measles coverage is very low and we are expecting more outbreak in urban areas. We recommend to MOPH to better enhance awareness and implement measles campaigns.


 Citation

Please cite as:

Karimi AS Sr

Evaluation of Routine Immunization Coverage in 12- to 23-Month Children in Sarepol Province, 2018: Descriptive Cross-sectional Study

iProc 2022;8(1):e36536

DOI: 10.2196/36536

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.